Edurne Vidal-Garcia
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Modulation of IRF7-driven transcription as a strategy to control HIV-1 latency.
Journal: Frontiers in immunology
Published: October 29, 2025
Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2- breast cancer.
Immune-based transcriptomic signature predicts CDK4/6 inhibitor efficacy in HR+/HER2- breast cancer.
Journal: Clinical and translational medicine
Published: May 20, 2025
Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.
Journal: International journal of molecular sciences
Published: April 04, 2024
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
Journal: International journal of molecular sciences
Published: November 02, 2022
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Journal: Frontiers in immunology
Published: July 22, 2022
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.
Journal: Frontiers in microbiology
Published: December 21, 2021
JAK-STAT Pathway: A Novel Target to Tackle Viral Infections.
Journal: Viruses
Published: November 11, 2021
Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713.
Journal: Cancers
Published: June 05, 2020
Last Updated: 09/26/2026